A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus

James Y. Dai, Jean De Dieu Tapsoba, Matthew F. Buas, Lynn E. Onstad, David M. Levine, Harvey A. Risch, Wong Ho Chow, Leslie Bernstein, Weimin Ye, Jesper Lagergren, Nigel C. Bird, Douglas A. Corley, Nicholas J. Shaheen, Anna H. Wu, Brian J. Reid, Laura J. Hardie, David C. Whiteman, Thomas L. Vaughan

Research output: Contribution to journalArticle

13 Scopus citations


Background: Important risk factors for esophageal adenocarcinoma and its precursor, Barrett's esophagus, include gastroesophageal reflux disease, obesity, and cigarette smoking. Recently, genome-wide association studies have identified seven germline single-nucleotide polymorphisms (SNP) that are associated with risk of Barrett's esophagus and esophageal adenocarcinoma. Whether these genetic susceptibility loci modify previously identified exposure-disease associations is unclear. Methods: We analyzed exposure and genotype data from the BEACON Consortium discovery phase GWAS, which included 1,516 esophageal adenocarcinoma case patients, 2,416 Barrett's esophagus case patients, and 2,187 control participants. We examined the seven newly identified susceptibility SNPs for interactions with body mass index, smoking status, and report of weekly heartburn or reflux. Logistic regression models were used to estimate ORs for these risk factors stratified by SNP genotype, separately for Barrett's esophagus and esophageal adenocarcinoma. Results: The odds ratio for Barrett's esophagus associated with at least weekly heartburn or reflux varied significantly with the presence of at least one minor allele of rs2687201 (nominal P=0.0005, FDR=0.042). ORs (95% CIs) for weekly heartburn or reflux among participants with 0, 1, or 2 minor alleles of rs2687201 were 6.17 (4.91-7.56), 3.56 (2.85-4.44), and 3.97 (2.47-6.37), respectively. No statistically significant interactions were observed for smoking status and body mass index. Conclusion: Reflux symptoms are more strongly associated with Barrett's esophagus risk among persons homozygous for the major allele of rs2687201, which lies approximately 75 kb downstream of the transcription factor gene FOXP1. Impact: The novel gene-exposure interaction discovered in this study provides new insights into the etiology of esophageal adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)1739-1747
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Issue number11
StatePublished - Nov 2015


ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Dai, J. Y., De Dieu Tapsoba, J., Buas, M. F., Onstad, L. E., Levine, D. M., Risch, H. A., Chow, W. H., Bernstein, L., Ye, W., Lagergren, J., Bird, N. C., Corley, D. A., Shaheen, N. J., Wu, A. H., Reid, B. J., Hardie, L. J., Whiteman, D. C., & Vaughan, T. L. (2015). A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiology Biomarkers and Prevention, 24(11), 1739-1747. https://doi.org/10.1158/1055-9965.EPI-15-0507